Nucleic acid treatment of disease or disorders, including cancer and diseases of the liver. “Protective effect of LNA-anti-miR-132 therapy on liver fibrosis in mice” Mol Ther Nucleic Acids.
It is built based on an open source image-viewing platform that integrated proprietary advanced 3D segmentation algorithms for solid tumors (e.g., in lung, liver and lymph nodes) and also contains a database with tumor segmentation and measurement results.
Aspects of this technology has been validated in mouse models, demonstrating high-resolution and chemically informative assessment of glucose metabolism in various murine tissues including tumors, brain, intestine and liver.
Identification of exosome-derived biomarkers that predispose to PGD after other organ transplant (e.g. lung, liver). Identification of molecular targets to prevent or treat post-heart transplant PGD.